As mentioned previously, it was apparent that the elevated expression level of Siglec15 relates to adverse prognosis and immune response in glioma patients, and we subsequently elaborated on the effect of Siglec15 in reshaping the tumor microenvironment. The gene discussed is SIGLEC15; the disease is central nervous system cancer.